Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paliperidone pharmacogenetic study in schizophrenia
ChiCTR-RPC-15007597Phase 4Not yet recruiting
- Sponsor
- The Second Xiangya Hospital
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of paliperidone in schizophrenia, sponsored by The Second Xiangya Hospital. Primary endpoints: Genotype and Plasma concentrations of paliperidone. Planned start Jan 2016; status: not yet recruiting.
02
Drugs
paliperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on ChiCTR-RPC-15007597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-RPC-15007597.